Design Therapeutics Inc logo

Design Therapeutics Inc

$ 14.73 +0.35 (+2.43%) 10:08 PM EST
P/E:
At Loss
P/B:
2.41
Market Cap:
$ 823.55M
Enterprise V:
$ 463.60M
Volume:
72.46K
Avg Vol (2M):
307.39K
Volume:
72.46K
Market Cap $:
823.55M
PE Ratio:
At Loss
Avg Vol (2-Month):
307.39K
Enterprise Value $:
463.60M
PB Ratio:
2.41
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 89.62
Equity-to-Asset 0.96
Debt-to-Equity 0.01
Debt-to-EBITDA -0.07
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 54.98
9-Day RSI 49.63
14-Day RSI 47.04
6-1 Month Momentum % 30.08
12-1 Month Momentum % -18.13

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 33.47
Quick Ratio 33.47
Cash Ratio 33.06

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -15.48
ROA % -15.07
ROIC % -985.55
ROC (Joel Greenblatt) % -1120.83
ROCE % -15.96

Financials (Next Earnings Date:2023-03-10 Est.)

DSGN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:DSGN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.03
Beta 0
Volatility % 78.59
14-Day RSI 47.04
14-Day ATR ($) 1.138789
20-Day SMA ($) 14.8885
12-1 Month Momentum % -18.13
52-Week Range ($) 9.61 - 26.3
Shares Outstanding (Mil) 55.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Design Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Design Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.